AbCellera Biologics: Pioneering Next-Gen Therapies Amid Market Volatility
AbCellera Biologics Inc. is a Canadian pharmaceutical company pioneering the development of next-generation therapeutic antibodies using advanced technologies, despite facing financial challenges in its stock market journey.
2 minutes to read